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Pyruvate Kinase Isoform M2 Influences Autophagy and
Related Processes in Hepatocellular Carcinoma Cells
Matthew Lin1, Department of Physiology & Neurobiology, University of Connecticut, Storrs,
Connecticut 06269
Abstract: Hepatocellular carcinoma (HCC) is the most common form of liver cancer that affects
~14 million people in the world. Like all cancers, HCC is a disease that arises from unstinted
cellular growth initiated by genetic alterations, metabolic changes, and dysregulation in key
cellular pathways. Of interest is the relationship between metabolism and cell
proliferation/degradation for therapeutic targeting. Pyruvate kinase M2 is a dimeric,
glycolytically inactive isoform of the final enzyme involved in glycolysis, that is often
upregulated in cancerous tissue. It is thought that the enzymatic function of PKM2 outside of
glycolysis contributes to the biosynthesis of anabolic intermediates used in cell growth and
division. Autophagy is a recycling process by which cells selectively degrade defective
components and is implicated in cell death pathways. Because PKM2 is upregulated in HCC
and links metabolism and tumorigenesis, we investigate its role in regulating autophagy and
associated processes. In this study, shRNA constructs were used to knockdown and
overexpress the PKM2 isoform in vitro to observe its effect on autophagy and related
processes, thus establishing a working model for how autophagy is regulated in HCC cells and
potential therapeutic targeting.

Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) represents 65% of liver cancer cases in the United
States.1 Across the world, HCC is the third most common cause of cancer-related deaths and
the number of HCC cases is expected to rise to 22 million in the next twenty years.2
Populations where hepatitis B virus is endemic have more prevalence of HCC: China,
Mongolia, Southeast Asia, and Sub-Saharan Western and Eastern Africa have a predominance
of HCC cases.1 Other causative factors include alcohol consumption and associated cirrhosis,
hepatitis C/D virus, and non-alcoholic fatty liver disease.1 Such assaults to the liver—namely
to hepatocytes, which comprise a majority of the tissue and carry out important metabolic,
biosynthetic, storage, and detoxification functions—predispose it to metabolic dysregulation
and oxidative injury, which leads to cycles of inflammation, cell death, repeated compensatory

2

University Scholar Thesis
regeneration, and accumulation of genetic mutations.3 HCC, then, can be understood as a
disease rooted in genomic alterations, metabolic changes, and regulatory dysfunction.
Currently, the Wang Lab in the Physiology and Neurobiology department at the
University of Connecticut has constructed a broad picture of hepatocellular carcinoma. It was
previously shown that the nuclear receptor small heterodimer partner (SHP) functioned to
suppress hepatic tumorigenesis as a pleiotropic regulator: modulating metabolic pathways,
the stress and inflammatory responses, detoxification, cellular adhesion and differentiation,
cell cycle control, and apoptosis.4 In addition, High-Mobility-Group Protein 2 was shown to be
highly induced in liver tumor initiating cells, and abrogating its function led to a decrease in
the pluripotency of tumor-initiating cells.5 Interestingly, metabolic regulator pyruvate
dehydrogenase kinase-4 (PDK4) has been implicated in the apoptosis pathway, as seen by
massive cell death events in mice with PDK4 knocked-out who were exposed to the
carcinogenic agent diethylnitrosamine (DEN).(unpublished) These findings illuminate the tortuous
molecular landscape of HCC, and provide insight into the links between metabolism,
tumorigenesis, and cell death.

Pyruvate Kinase
Pyruvate kinase (PK) is the rate-limiting enzyme in the last step of glycolysis. By
removing the phosphate group from phosphoenolpyruvate and transferring it to an ADP
molecule, PK catalyzes the formation of a pyruvate and an ATP molecule. There are four
isoforms of pyruvate kinase in humans, and each one is associated with a different tissue
type. PKL is expressed primarily in the liver; PKR is found in red blood cells; PK isoform M1
(PKM1) is localized in most adult tissues with high ATP requirements; and PK isoform M2
(PKM2) is a splice variant of PKM1, whereby exon 10 is included in place of exon 9, and it is
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associated with embryonic tissue.6 Interestingly, PKM1 in its canonical form exists as a
tetramer and is metabolically and glycolytically highly active; however, PKM2 is primarily found
in a dimeric form that is less glycolytically active, but is preferentially upregulated in cancerous
tissue. It is thought that expression and activity of dimeric PKM2 endows cancer cells with the
aerobic glycolysis activity characteristic of the Warburg effect.7,8 In fact, it has been shown
that the dimeric form of PKM2 might have enzymatic function outside of the metabolic
pathway such as shunting resources to biosynthesis, phosphorylating downstream proteins
like SNAP-23 for exosome formation and secretion into the tumor microenvironment,
contributing to chromosome segregation, interacting with proteins that form contractile rings
for cytokinesis, and activating chaperone-mediated autophagy.9,10,11 A study by He et al.
examined renal cell carcinoma and breast cancer to illustrate the phosphorylative ability of
PKM2 and its role in inhibiting autophagy through AKT1S1 S202/203 phosphorylation, which
activates mTORC1 and abrogates ATG1 complex formation.12 Furthermore, studies have
shown that knocking-down PKM2 in lung carcinoma cells increased autophagosome
formation, while overexpressing PKM2 accelerated oncogenic proliferation and inhibited
autophagy in cancer cells.13,14 Because PKM2 is involved in the glycolysis pathway upstream
of PDK4—which we have previously identified as a regulatory agent of apoptosis in carcinogenchallenged mice—and because its role in tumor progression, anabolic potentiation, and cell
death is clearly associated, it represents an interesting target of autophagy and study in the
context of HCC.
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Figure 1. (A) Tumor cells preferentially express dimeric PKM2 that funnels glycolytic intermediates into
biosynthetic pathways.15 (B) Tetrameric PKM2 pushes glucose intermediates towards pyruvate formation,
while low PKM2 leads to biosynthesis.9
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Autophagy
Autophagy is a cellular recycling process by which cells degrade intracellular
components, including targets that are too large for other degradative systems, in response
to external and internal stressors. In essence, autophagy functions as a third arm of cellular
clearance, with the other two being apoptosis and necroptosis. There are three categories of
autophagy: macroautophagy, microautophagy, and chaperone-mediated autophagy.16
Macroautophagy is the best characterized form of autophagy in cells. Briefly, the molecular
mechanisms of autophagy require a stress stimulus that causes formation of doublemembrane vesicles, which engulf cytoplasmic contents and fuse with lysosomes that degrade
captured substances. Important proteins that mediate this process are LC3, which is the
commonly used name for microtubule-associated protein 1 light chain 3 and is a ubiquitinlike molecule; Beclin-1, which connects the apoptosis and autophagy pathways through its
binding to apoptosis inhibitor Bcl-2, and also helps localize autophagic proteins to preautophagosomal structures; and Vps34, which is a vesicular protein sorting enzyme that binds
Beclin-1 and acts as a PI3-kinase that is essential to phagophore elongation.17,18,19 In cancers,
autophagy-associated cell death and autophagy more generally is purported to act as a tumor
suppressor, and loss or inhibition of autophagy is correlated with genomic instability, necrosis,
and apoptosis.13,20,21 Nevertheless, autophagy appears to be context-dependent as it can also
help increase tumor survival, thought to provide metabolites from degradation as substrates
for anabolic reactions.22 Reviews of anticancer compounds have confirmed this dual-nature
of autophagy, with certain compounds such as aminoquinolines working via inhibition of
autophagy purportedly repressing cancer activation, and other drugs inducing autophagy to
prevent tumor progression.23 It has been observed, however, that overwhelming activation of
autophagy and the accumulation of autophagolysosomes leads to autophagy-associated cell
6
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death.24 There is controversy in the field whether this event is causal or incidental to cell
death.24 While debated, it is of interest to understand the regulation of autophagy in cancer
cells because therapeutics that induce autophagy synergize with autophagy inhibitors for
anticancer effects both in many cancer cell lines and in xenograft models.
Moreover, the link between PKM2 and autophagy has been established. PKM2 is often
acetylated in high glucose concentrations, which decreases its activity and promotes its
lysosomal-dependent degradation via chaperone-mediated autophagy.9 The presence of
acetylated PKM2 conferred tumor growth advantage both in vitro and in vivo for lung
carcinoma tissue.7 In addition, the knockdown of PKM2 in lung carcinoma cells led to induced
apoptosis and autophagy; upon inhibition of autophagy with chemical inhibitor 3methyladenine (3-MA), apoptosis was observed in higher frequency.13 P300/CBP-associated
factor (PCAF) overexpression was shown to promote cell autophagy and elicit cell death in
Huh7 and Hep3b HCC cell lines.21 In the Wang lab, RNA-seq analysis of hepatocellular
carcinoma mouse samples probed for upregulation of certain genes and was able to isolate
a panel of cell-cycle and glycolytic enzymes that exhibited differential expression (Figure 2).
However, many human samples have been confirmed to show an increased expression of
PKM2.25 Thus, the proposed experiment will modulate the expression levels of PKM2 to
observe its effect on autophagy and associated cell death or other processes among HCC cell
lines.
Figure 2. RNAseq heat map of select genes
up- and down-regulated in DEN-induced mice
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Methods & Materials
Cell Culture
Human embryonic kidney cell line HEK293T, and human hepatocellular carcinoma cell lines
Huh7 and Hep3B cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM,
25 mM glucose; Life Technologies). All mediums were supplemented with 10% fetal bovine
serum and 1% antibiotics (100 U/mL penicillin and 100 U/mL streptomycin). Cells were
maintained at 37ºC in a humidified cell incubator at 20% O2, 5% CO2 in air (normoxia
conditions).
shRNA plasmid isolation
Two short-hairpin RNA constructs were used to target PKM2 messenger RNA. Two bacterial
stocks of MISSION shRNA were purchased from Sigma Aldrich as glycerol stock:
TRCN0000291062
(#2: 5’-CGGCTTTCCTGTGTGTACTCTGTCCTCGAGGACAGAGTACACACAGGAAAGTTTTTTG-3’), which
targets the terminal end of coding sequence from amino acid 325 to 345, and
TRCN0000296768
(#8: 5’-CCGGGTTCGGAGGTTTGATGAAATCCTCGAGGATTTCATCAAACCTCCGAACTTTTTTG-3’), which
targets at the 3’UTR. Bacteria were streaked on ampicillin-positive LB-agar plates and
incubated overnight at 37º. 18 hours following inoculation, several colonies were selected
and transferred to tubes of ampicillin-positive LB media and shaken overnight at 37º.
Following an additional 18 hours, these solutions were collected and mini-prep plasmid
purification (Qiagen) was carried out. Plasmid was quantified by NanoDrop spectrophotometry
analysis and placed into sterile tubes for storage.
Lentiviral Infection
Purified plasmid was transfected into HEK293T cells using lipofectamine reagent
polyethylenimine (PEI). Briefly, purified shRNA, pMD.2G (VSVG envelope) and pPAX (groupantigen gene “gag” and polymerase) were mixed together with 1:2 wt/vol PEI and 1:100
wt/vol and Dulbecco’s Modified Eagle’s Medium (DMEM) and incubated at room temperature
for 30 minutes.26 Target cells (Huh7/Hep3B) were seeded 24 hours prior to transfection to
allow for surface adhesion but optimized exposed surface area for liposome contact.
Packaged lipofectamine solution was then added dropwise to each well and shaken to evenly
apply across the monolayer. Media was changed 6 hours later to wash out remaining PEI,
which is toxic to cells. Viral titers were collected using a 0.45 nanopore filter and syringe every
24 hours for 3 days. Fresh media was added after collection each day. Collected viral media
was added dropwise to target cells (Huh7/Hep3B) each day for 3 days. Transduced cells were
allowed to grow and selected using puromycin. Knocked-down expression was monitored with
western blot analysis. See Figure 9A for a schematic of this technique.
Viral Ultracentrifugation
Collected viral media was pooled into a sterile 50-mL Falcon tube and stored at 4ºC over three
days of collection. At the end of collection, samples were transferred to autoclaved
polypropylene tubes and balanced with DMEM media. Equal volume and mass samples were
then centrifuged for 2 hours at 25,000 rpm at 4º. Supernatant was poured off and viral pellets
were reconstituted in 500µL of complete media. Typically, titers would be measured of these
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samples; however, due to time constraints and low volumes, all viral solutions were used to
treat the target cells for experimentation.
Transient Plasmid Transfection
DNA/shRNA constructs were packed into lipofectamine nanoparticles as described
previously. Packaged particles were applied dropwise to cells 24 hours after they had been
seeded. Media was changed 6 hours post-transfection and cells were selected using
puromycin. Experiments were conducted in the 3 days following transient transfection to
ensure that expression of plasmid was maximized.
Autophagy starvation experiment
Autophagy can be induced chemically (rapamycin) and metabolically (through starvation).27,28
One control and two knockdown cell lines were subjected to three media conditions. Control
groups were incubated in complete media 24 hours; group 2 were incubated in DMEM for 48
hours; group 3 were incubated in DMEM for 72 hours. Each of these three groups were used
for each treatment group (control, knockdown, overexpression, etc.). Cells were collected for
Western Blot Analysis at each time point by washing them with phosphate buffered saline
(PBS), scraping with a cell scraper, and transferring to a sterile tube. Cells were centrifuged at
15,000xg for 30 seconds and supernatant was aspirated. Cells were reconstituted in lysis
buffer and incubated on ice for 10 min. Lysis solution was centrifuged for 15 minutes at
12,000xg at 4ºC. Supernatant was transferred to a sterile tube and quantified using BCA.
Overexpression + Inhibition/Induction of Autophagy
E. coli transformed with PKM2-GFP was grown on kanamycin-positive LB-agar plates. Colonies
were isolated and inoculated into kanamycin-positive LB media and shaken overnight, as
previously described. Plasmid were purified via Qiagen mini-prep and quantified via nanodrop
absorbance spectroscopy. Plasmid was transfected transiently into Huh7 and Hep3B cells
and selected via fluorescence activated cell sorting (FACS) for growth. Overexpressed PKM2
cells were subjected to starvation experiment conditions and monitored for PARP cleavage
and p70S6 kinase cleavage, both markers for apoptosis.29 In addition, MTS cell viability
assays and TUNEL staining or Annexin V/PI flow cytometry were conducted for functional
analysis.
For inhibition of autophagy, cells that were virally transduced were selected using FACS sorting
and allowed to grow. Autophagy inhibitor (3-methyladenine/anti-ATG/chloroquine) was given
in increasing doses and WBA was analyzed to observe effect on starved cells at different time
points.30 Markers of autophagy and apoptosis were monitored using WBA.
For induction of autophagy, cells that were virally transduced to knockdown expression of
PKM2 were co-cultured with rapamycin, a potent autophagy inducer. Similar analytical
methods were conducted as for the overexpressed/inhibited cells.
Western Blot Analysis & Quantification
Protein lysates were collected and quantified via bicinchoninic acid assay (Pierce BCA Assay),
using bovine serum albumin standards as reference controls. Once total protein
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concentrations were quantified in samples, equal quantities of protein sample were loaded
into 8-15% agarose gels and run at 80-100mV for 90-120 minutes. Bands were transferred
to nitrocellulose membranes by applying a 100 mV electrical field across the gel and between
sponges in transfer buffer (Tris + glycine, H2O, MeOH) for 2 hours at 4ºC. Post-transfer
membrane was then blocked with 5% milk for 30 min. to 2 hours. Blots were then probed with
anti-PKM2, anti-LC3b, and anti-actin before applying secondary anti-rabbit antibody linked to
HRP. Bands were visualized via enhanced chemiluminescence (ECL). Quantification of bands
was conducted using the ImageJ imaging program.

Results
Knockdown of PKM2 isoform in Huh7 cells led to an increase in autophagosome formation.
The relationship between pyruvate kinase M2 expression levels and autophagy levels
were analyzed in vitro. The Huh7 cell line (originally isolated from a 57-year-old Japanese
patient with well-differentiated HCC) was chosen for its demonstrated ability to be readily
transfected and manipulated.31,32 To conduct knockdown experiments, two short-hairpin RNA
(shRNA) constructs that were validated as 99% efficient were purchased from Sigma-Aldrich.
Upon first pass viral packaging and transduction, the packaging cell line appeared to die in
large quantities (not shown); nevertheless, the target cells thus seemed to exhibit noticeable
decrease in protein levels of PKM2 in both knockdown conditions, though efficiency was not
very high (Figure 3). All expression levels were normalized to the short hairpin non-targeting
(shNT) control, with sh#2 showing about half expression at 0.51 and sh#8 knocking down
expression to 0.40 of the control level’s (Figure 3). A second set of viral packaged cells were
established after the first set died from cell damage. It was noted that 293T cells are
particularly susceptible to mechanical agitation and often lifted off of the bottom of the cell
culture dish upon the slight perturbation. To improve the technique of viral transfection, all
solutions were added in a dropwise-fashion across the surface, rather than down the sides of
the dishes. The second-line of cells that were established were much healthier.

10

University Scholar Thesis
Once this second line of healthy, knocked-down cells was confluent, it was seeded for
the starvation experiment. Western blot analysis was used to visualize the knockdown effect
in the cells, as well as a measure of autophagy levels. The knockdown effect was observed to
increase as starvation period increased (Figure 4). Autophagy levels were observed through
anti-LC3B probing. Due to a low efficiency knockdown, the levels were not significantly
different across treatment groups (not shown). A third round of experimentation was
conducted to improve knockdown efficiency in these cells.
After several more attempts at viral transfection, an efficiently knocked down line of
Huh7 cells was established (Figure 5A). Knockdown efficiency was quantified and normalized
to the shNT control group. The effect of sh#2 was most dramatic, with an 88% decrease in
control conditions, a 94% decrease at 48 hours starvation, and an 84% decrease at 72 hours
starvation. By contrast, sh#8 was not as efficient but still showed a significant level of
knockdown: at control conditions, cells had a 55% lower level of PKM2 expression; at 48
hours, it was 78% lower; and after 72 hours, it was 75% lower (Figure 5B).
Protein levels of LC3B expression were probed across treatment groups to detect
autophagosome formation, a hallmark of increased autophagic processes. Two bands are
detected with aLC3B probing: the heavier band is LC3B-I (19 kDa), a cytosolic protein originally
believed to aid in microtubule association and dissociation; the lighter band is LC3B-II (17
kDa), a ubiquitylated form of LC3B-I that is only formed after autophagosome formation by
E1-ligase-like Atg proteins and subsequently degraded by lysosomal proteases when
autolysosomes form.33 Thus, the presence of LC3B-II in relation to LC3B-I is more indicative
of autophagosome formation and autolysosomal processing. To this end, relative expression
of these two bands were quantified. It was seen that sh#8 cells at 48 and 72 hours had a
relative increase in LC3B-II levels, with .27 and .63 greater II:I signal ratio than the control-
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treated cells (Figure 5C). Sh#2 cells also showed a similar increase, though to a lesser extent
than sh#8-treated cells, with a 0.1 and 0.01 increase in ratio (Figure 5C). An actin
housekeeping gene control is shown. Loading of protein samples across the treatment groups
was relatively the same and any differences were statistically insignificant (Figure 5D).
Therefore, it appears that Huh7 cells that show a knockdown of PKM2 expression also
exhibited increased levels of autophagy.
Knockdown of PKM2 isoform in Hep3B cells was difficult to establish.
To investigate whether this knock-down effect and increase in autophagic processes
was a cell line-specific phenomenon, an additional colony of carcinoma cells were established
and manipulated. Hep3B was originally isolated via biopsy from an 8-year-old Black male, and
has been well-studied and characterized.34 This line was chosen for its wide availability,
expression of enzymes, and its ability to tolerate a variety of culture conditions. However, the
establishment of a stable knock-down line proved to be exceedingly difficult in my time
working with the line.
Initially, viral-transduction knockdown was attempted to produce a stable line. A 293T
packaging line was established once more and viral media was applied to Hep3B cells for 3
days. Since sh#8 seemed to produce the greatest knockdown and autophagy-inducing effects
in the Huh7-line, it was used as the sole knockdown agent. However, WBA revealed that the
expression of PKM2 appeared to increase upon infection with sh#8-containing lentivirus,
despite proper loading of the gel (Figure 6). It is possible that the samples were loaded
improperly into the gel, but this seemed unlikely given the careful monitoring that I employed
throughout my experimentation. A second line of 293T packaging cells was established and
viral media was collected for application to another set of Hep3B cells. In addition, a sample
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of packaging cells was collected for WBA, which revealed that there was little knockdown
effect seen (Figure 6).
A third iteration of virally-transduced Hep3B cells was attempted, this time using a
greater concentration of shRNA in liposomes with the hopes that a greater percentage of
lentiviral particles contain these sequences. Knockdown effects were still paradoxical in
presentation, with cells purportedly receiving the knockdown viral treatment showing no
difference in PKM2 expression or even heightened levels of expression. Probing for autophagy
markers revealed a sporadic expression of LC3B-II: control condition knockout cells appear to
have slightly elevated LC3B-II presentation compared to NT control; 48 hour starvation knock
down cells show a similar level of heightened autophagy; however, 72 hour starvation
knockdown cells have almost no autophagy levels when compared with NT control; the lower
levels of autophagy also was seen in 293T cells (Figure 7). A fourth attempt at viraltransduction was made in conjunction with transient transfection – a process that involves
direct transmission of shRNA plasmid into cells via lipofection. The packaged cells showed
little to no knockdown effect, and the transiently transfected cells also exhibited minimal
knockdown effects (Figure 8). Nevertheless, a starvation experiment was conducted to see if
autophagy levels was different among these manipulated cells. Unfortunately, the loading of
the gel was poor and resulted in a blot that was difficult to interpret (Figure 8). Probing for
LC3B proved to show almost no levels of autophagy since the presence of processed LC3B-II
was not detected. The poor transfection efficiency could be attributed to the timing and
seeding density of the cells; because the cells had been seeded a few days prior to
transfection, and because the dishes were 80-90% confluent, the surface area of cells was
not as optimal as it would be at 24 hours post-seeding and the division rate of cells was also
not as rapid (Figure 9).
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A fifth attempt at virally-transfecting 293T cells and lentiviral transduction of Hep3B
cells was undertaken utilizing ultracentrifugation. As detailed in the Materials & Methods
section and briefly detailed here, viral media was collected from transfected 293T cells every
24 hours over the course of 3 days; each time viral media was taken up by syringe and pooled
into a sterile Falcon tube through a 0.45 nm pore filter, after which fresh DMEM media was
added dropwise to the cells. After all media had been pooled, the entire volume was
transferred to a sterile polypropylene tube and ultracentrifuged for 2 hours at 25,000 rpm at
4ºC. Reconstituted virus was then applied to Hep3B cells to infect and incubate for 3 days. A
series of puromycin selection was used to allow for transduced cells to grow out into the
population; however, upon WBA it appeared that this method of concentrated viral infection
still could not yield a meaningful knock down phenotype (Figure 10). A last attempt using
optimized transient transfection techniques failed to produce a knocked down phenotype of
PKM2 in Hep3B cells (Figure 11).
Overexpression of PKM2 in Hep3B cells led to a decrease in autophagosome formation.
The next logical step in understanding the role of PKM2 in autophagy was to observe
the effects of overexpression within cells. Due to the time constrains of this project, it was
thought that utilizing Hep3B cells for both knock down and overexpression studies would be
most economic, even with the ongoing difficulties of manipulating gene expression in this line.
In order to overexpress PKM2, a plasmid containing this gene under a constitutive promoter
was isolated and transfected into cells. The construct was the pPKM2-EGFP plasmid that was
isolated from bacterial agar stab stock. A pCMV-FLAG empty vector was used as a negative
control. Initially, overexpression plasmid was purchased as a bacterial stock stored in an agar
stab and stored at -20ºC. However, reconstitution and streaking of this stock did not produce
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any viable colonies, even after three attempts (data not shown). Luckily, Dr. Jianguo Wu had
a previously isolated concentrated sample of plasmid that was produced from an earlier
experiment, which he kindly gifted for my experimental use. These two plasmids were
combined with PEI at 2µg/well and transfected transiently. First pass transient transfection
was unsuccessful and produced cells that had no differences in PKM2 expression (Figure 12).
In addition, the use of a thinner gel and lower well volume led to improper loading that leaked
across well boundaries, thus resulting in staggered bands with bleeding. After two more
attempts, however, the level of PKM2 expression was greatly increased in pPKM2-EGFP
transfected cells when compared to pCMV-FLAG treated cells (Figure 13). Control condition,
overexpression cells had a 1.37-fold increase in PKM2 expression, 48-hour starved
overexpressed cells showed a .39-fold increase, and 72-hour starved overexpression cells
had a 0.25-fold increase compared to empty vector control (Figure 13B). It is also notable that
expression of PKM2 decreased over the course of starvation in control cells, thus making the
relative greater expression of PKM2 in treated cells all the more significant (Figure 13B).
Probing these cells for autophagy markers led to the interesting finding that increased
PKM2 expression also increased the formation of autophagosomes in starved media
conditions (Figure 13D-F). The effect of induced autophagy was not as drastic as that of the
knockdown conditions seen previously; however, control condition overexpression cells
exhibited a 0.06 decrease in ratio, 48-hour starved overexpression cells show a 0.19
decrease, and 72-hour starved overexpression cells show a 0.42 increase in ratio (Figure 13DF). Unfortunately, time constraints did not allow for the probing of actin controls to normalize,
but these findings show some preliminary evidence that overexpressed cells have a more
complex mechanism of autophagy induction when metabolically challenged than previously
thought. Thus, overexpression of PKM2 in Hep3B cells led to a mild decrease in autophagy of
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control and minimally starved cells, but a large increase in starved cells that were challenged
for a longer period of time.

Discussion
In this study, I show that modulating the level of pyruvate kinase isoform M2 led to a
change in the levels of autophagy. More specifically, the knockdown of PKM2 in Huh7 led to
an increase in autophagosome formation and autolysosome function, which are functionally
indicative of autophagy and related processes. As demonstrated by the several western blots,
the knockdown efficiency of Huh7 cells was between 50-94%, with sh#2 treatment being the
more efficient of the two shRNA constructs used. The levels of autophagy do not seem to
exhibit a linear relationship with levels of knockdown, however. At the lower efficiency sh#8
knockdown (i.e. “mild” knockdown) levels, the levels of autophagy were .41-fold and .70-fold
greater at 48- and 72-hours starvation, respectively (Figure 5D). Assuming cancer cells have
a greatly increased drive to divide and proliferate, it might be a possibility that the “mild” KD
effect is downregulating the dimeric, biosynthetic activity of the PKM2 dimer form found in
most cancers.35 In this way, the previously productive rate of biosynthesis would slow, and
dividing cells would require the replenishment through alternative means in starved
conditions, namely autophagy. Higher efficiency knockdown has the effect of severely
dampening biosynthesis in hepatocytes, and thus the rate of division either decreases or cell
death occurs through a variety of means. Indeed, upon examination of the cell culture dish,
the morphology of cells in the sh#2 treatments was smaller in size than other cells as well as
less confluent upon collection (data not shown). To this end, a working model of knocked
down PKM2 cells is shown in Figure 15.
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Knockdown of PKM2 in Hep3B cells was difficult to produce, and the effect on autophagy as
seen in Huh7 cells could not be replicated.
Two approaches were conducted to try and establish a stable line: (1) viral transduction and
(2) transient transfection. The first attempt at packaging and infection was done with 1.5µg
of DNA and the two envelope and packaging viral components. Several errors were made that
probably contributed to the low infectivity and transduction, including but not limited to not
aspirating old media off of target cells after viral application (leading to dilution of newly
introduced virus), adding puromycin selection agent too early before colonies of transfected
cells could grow, and/or poor handling of 293T packaging cells that lifted off the bottom of
the cell culture plate. A second round was conducted, ensuring that all media was added
dropwise to 293T cells in a manner that did not disturb them, and carefully aspirating off old
media when applying new viral media. A possible reason why this did not yield high efficiency
was due to the confluency of Hep3B cells upon starting transduction (Figure 14). A third
iteration was then carried out, but was established a week prior to spring break, wherein the
prepared cells were not collected and died due to a miscommunication between my post-doc
mentor and myself. A final fourth and fifth attempt was made to virally transduce the cells
with no success, possibly due to the high passage number of the target cells.
The second method of transient transfection followed standard protocol. The first time
it was carried out, the Hep3B cells were likely too confluent and led to poor uptake. On second
trial, the master mix of transfection solution was not properly made, since PEI was added in
3x too high of concentration; since it is toxic to cells, this led to a high percentage of cell death
rather than higher efficiency as I had wishfully surmised. The third repetition of this technique
yielded surprisingly low concentrations of protein, especially for the knockdown and starved
cells despite collecting almost equal volumes of cells from culture. This imbalanced loading
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into the gel contributed to the apparent knockdown phenotype observed in Figure 11. Due to
these complications, a stable line was not able to be established in the time I worked in the
lab and must be optimized further to validate our initial findings seen in Huh7 cells.

Overexpression of PKM2 in Hep3B cells led to metabolically-dependent induction of
autophagy.
Due to the low success of viral transduction and establishment of stable lines for knockdown,
transient transfection was chosen as the sole method for observing overexpression effects.
Three attempts were made to transiently transfect a pPKM2-EGFP plasmid under a CMV
promoter, which was successfully observed as seen in Figure 13. Overexpression levels were
observed at 2.37-fold, 2.27-fold, and 2.05-fold greater levels than their respective control
treated cells (Figure 13). Overexpression efficiency was observed at a higher rate in part
because this level includes non-transfected cells that are expressing PKM2 concurrently, and
in part because producing more product biologically requires fewer steps than the inhibition
by silencing complexes like RISC. Probing these cells for LC3B showed that complete media
conditions led to a 0.10-fold decrease in LC3B-II appearance, 48-hour starvation led to a 0.22fold decrease in appearance, but 72-hour starvation correlated with a 0.49-fold increase in
appearance for overexpression cells (Figure 13). The levels of autophagy here are surprising,
but not unexpected according to the paradigm initially hypothesized from the knock down
data. According to the model, higher overexpression of PKM2 would lead to greater basal
levels of biosynthesis; therefore, only during severely starved conditions will the cancer cell
turn towards autophagy (Figure 15). Extrapolating this further, it might be that mild levels of
overexpression (i.e. a more active form of the canonical tumor cell that highly expresses this
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isoform) leads to lower levels of autophagy across all starvation conditions. These findings
must be validated further using additional cell culture studies.

Resource Depletion-Induced Autophagy Model
From these preliminary findings and extrapolation, a working model for induction of autophagy
in knockdown and overexpressing PKM2 cells was hypothesized. According to this model,
resources for cell hyperproliferation are required for the cancerous tissue. A cell that requires
greater biosynthetic intermediates requires either a heightened rate of anabolism, or a rapid
rate of component recycling. At low expression levels of PKM2, the dimeric and nonglycolytically active form does not push the cell towards biosynthesis pathways an effectively.
As such, the cell must increase its autophagic processes to compensate for this drop in
resources, which exacerbates as the cell undergoes starvation conditions. For a certain
amount of time, the cell is able to replenish its depleted intermediates until, at a critical point
(the start of the “therapeutic window”), the cell loses its ability to survive the degradative
turnover of its components and leads to greater instances of cell death (Figure 15A). It is
thought, therefore, that inducing greater autophagy in these knocked down cells could induce
higher levels of turnover that lead to cell susceptibility to death.
By contrast, the model also accounts for the overexpression of PKM2 in HCC cells and
the observation that autophagy also increases, though at later stages of starvation. Because
higher levels of dimeric PKM2 are present in the cells, there does not need to be as high levels
of autophagy in normal, or even in early stages of starvation. However, past a critical point
(“therapeutic window”), the cell must turn to autophagy to restore its depleted resources for
cell proliferation. The rate of autophagy was observed to be much higher at these later stages
of starvation, and therefore the recycling pathway must be working at increased levels to
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compensate for the sudden withdrawal from anabolic processes catalyzed by increased PKM2
levels (Figure 15B). As such, it would be therapeutically targetable to inhibit autophagy in
these cells under such high metabolically stressed conditions in order to push the cell farther
towards apoptotic pathways. Due to the interplay between apoptosis and autophagy and the
general trend that tumor cells preferentially express PKM2, this method of autophagic
inhibition is hypothesized to work particularly well as a therapeutic treatment.16 In both
instances, it would be interesting to observe the potential synergistic effects of other
pharmacologic agents that take advantage of the altered metabolism of cancer cells.
Though the amount of reportable data and findings from this University Scholar project
was minimal, a great deal about molecular biology, physiology, and liver cancer techniques
and experimental approaches was imparted to me. Perhaps the greatest takeaway is the hard
work needed to conduct cell culture studies, the fact that cells often do not behave in ways
that are predictable owing to the complexity with which they grow, divide, and proliferate, and
the difficulty in successfully manipulating gene expression within cells. Transfection efficiency
proved to the limiting factor across all the experiments conducted in this study. Even with
optimizing concentrations, times of transfection, media, and lipofection agents, efficiencies
rarely approached that of other published studies – a benchmark of industry
standards/standards of the field. To this end, the follow-up studies I had planned on
conducting to more fully understand the complex interaction between PKM2 and autophagy
could not be completed in the few semesters I had to work in the lab. On top of coursework
and other things, balancing time to schedule experiments and troubleshoot was a significant
logistical challenge. Nevertheless, this experience points to the need for dedicated research
periods, which I look forward to pursuing in my graduate studies. Overall, my experience with
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this project yielded a few interesting findings and affirmed my passion to continue biomedical
research in pursuit of basic science and translational knowledge.

A few future directions are necessary to flesh out the larger picture of PKM2’s role in
autophagy in HCC cells.
First, a secondary line of HCC cells must be established to recapitulate the findings of
the Huh7 knockdown cells. This is to ensure that it is a HCC-specific observation that is
validated across multiple cell types, rather than a severely limited sample set. Hep3B cells
have been shown to be able for transfection, and the overexpression data demonstrate that
it is possible. To optimize this protocol further, I might also purchase or synthesize addition
shRNA constructs that have higher target ability and use a greater concentration and larger
cell population. I would expect to see a similar level of knockdown efficiency in the cell line
followed by a concomitant increase in autophagy levels for knockdown and starved cells.
Concurrently, I would repeat the overexpression study in the Huh7 cell line to observe
autophagy levels. In addition, I might try to modulate the overexpression levels of PKM2
through chemical means (CHX translation inhibition) in order to further support the working
model hypothesized. I would expect to see an effect of increased autophagy only in greatly
starved/stressed cells. In other words, I would expect to see lower levels of autophagy
compared to basal level controls in conditions that are optimal for tumor growth, and these
levels would increase in a direct relationship to the level of PKM2 expression (decreasing
levels of CHX treatment.)
In addition to working with flat, one-dimensional cell culture, I would attempt to use
tumor spheroids in vitro because they have been shown to be more realistic in simulating invivo tumors.36 The establishment of knockdown and overexpressed cells would require the
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use of the rotary cell culture system.37 In this system, cells are grown in standard cell culture
and then isolated as single cells and grown in a rotating flask so that they do not adhere to
the sides. WBA and other techniques could be used in the same fashion to probe for changes
in autophagy as in monolayer flasks, though more complex imaging and diagnostic tests could
be used to observe overall phenotype and morphology as well as metastasis.
Once these findings have been observed, I would move on to establish ties to clinical
significance. The following are the experiments I would carry out to investigate whether the
modulation of autophagy levels synergizes current cancer therapies, or if it can alter the
metabolic function of cancer cells to meaningfully reduce their oncogenic characteristics and
decrease tumor progression.
I would attempt to exploit the therapeutic windows of autophagy and cell survival
established by my model. By targeting the knockdown cells at the higher end of autophagy, in
essence inducing greater levels of autophagy, I predict a decrease in cell viability due to
autophagy-associated death. To accomplish this, I would apply autophagy inducers in addition
to knockdown constructs, and observe cell viability using an MTS assay, PARP cleavage, or
flow cytometry (AnnexinV/PI). I would expect to see a greater level of cell death in cells that
have been knocked down and autophagy-induced. Furthermore, I would observe whether
these effects synergize with those of other HCC drugs currently on the market or in Phase II
clinical trial in an attempt to improve their efficacy.
Conversely, I would attempt to target the mutually-inhibitory relationship between
autophagy and apoptosis for overexpressed cells.16 According to the RDAM model, I would
target the low autophagy levels at normal media conditions and inhibit autophagy further,
using the chemical inducer 3-MA and measure cell viability. These effects should be magnified
upon metabolic starvation since the cells should attempt to rescue their proliferative ability
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through autophagy but will instead undergo an apoptotic pathway. I would expect to see lower
cell viability throughout all conditions, with a steep drop in viability at highly metabolically
stressed cells. This effect could also be synergizing with other therapeutics and should be
explored to find an appropriate pairing that could be clinically applicable.
I would then move to in-vivo mouse models to validate these findings in a living model
system, with the hopes of establishing phenotypic and functional pre-clinical significance. By
using patient-derived xenografts in SCID/NOD mice, I would measure tumor size and observe
histology of treatment with autophagy inhibitors, and knockdown constructs + inducers +
therapeutics. I would expect to see a decrease in tumor size for fasting mice upon treatments,
with greater levels of cell death upon autophagy induction for knockdown-treated cells and
upon apoptosis induction for overexpressed cells. A Kaplan-Meier curve could be constructed
for a group of mice to be monitored over a longer time course to see if treatment is a viable
mode of clearing a tumor and allowing for increased survival.

Final Remarks
Overall, this study provides an interesting claim that PKM2 modulates the activity of
autophagic properties to aid in the proliferation and growth of HCC cells. By changing
expression levels within cells, it is possible to induce a resource-depletion-induced flurry of
autophagy activity and establish a therapeutic window to either increase or decrease
autophagy and lead to cell susceptibility to death. In total, this project demonstrates that HCC
cells have autophagy processes that are influenced by PKM2 expression, and that this
pathway requires greater investigation for potential further clinical application.
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Figure 3. Knockdown levels of PKM2 in first-pass 293T viral-packaging cells is not efficient.
Relative expression of protein was analyzed via ImageJ software and signal was calculated as
area under the curve (AUC). Expression levels were normalized to non-targeting control levels.
Top arrow indicates the bands at ~58 kDa, the predicted monomeric form of PKM2; bottom
arrow indicates either a non-specific binding of antibody, or Hsp40, a binding partner of PKM2
in its glycolytically inactive state.38
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Figure 5. Huh7 cells virally-transduced appear to have knockdown phenotypes. (A) Efficient
knockdown of PKM2 in Huh7-transduced cells. (B) Quantification of knocked down expression
in Huh7 cells. (C) Knockdown cells show an increase in LC3B-II expression (lighter band) in
comparison to LC3B-I expression (heavier band). (D) Actin control shows equal loading
concentrations.
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Figure 6. Initial lentiviral knockdown exhibited paradoxical PKM2 expression. On left, PKM2
expression appears to be greater in shRNA-treated cells than in non-targeting control cells. On
right, actin controls are shown for both samples.
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Figure 7. Inefficient transfection and transduction yields unpatterned expression of PKM2 and
LC3B-II. (A) 293T transfected cells do not show PKM2 knocked down expression. (B) Nonefficiently virally-transduced Hep3B cells have differential PKM2 expression, virallytransfected 293T packaging cells show no knock down effect. (C) Hep3B cells show variable,
but low levels of autophagy.
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Hep3B cells. (A) Transiently transfected Hep3B cells cannot be meaningfully interpreted due
to loading errors. (B) Almost no levels of autophagy were detected.
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followed by western blot analysis. (B) Optimal seeding of target cells prior to transfection.
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Figure 10. Ultracentrifuged concentrated lentivirus yields no efficient transduction of Hep3B
cells.
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Figure 11. Transiently transfected knockdown in Hep3B cells. The drop in PKM2 expression
of sh#8-treated cells at 48 and 72 hours was due to low concentrations and therefore
decreased amount of protein available to load into the well.
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Figure 12. Initial overexpression transfection showed no signs of upregulated expression of
PKM2.
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expression of PKM2 in Hep3B cells. (A) PKM2 overexpression. (B) Table of quantified
expression levels. (C) Graphical representation of quantified data as in (B). (D) LC3B-probed
WBA. (E) Quantification of LC3B-II ratio to LC3B-I. (F) Graphical representation of quantified
data as in (E).
MW
pCTL pPKM2 pCTL pPKM2 pCTL pPKM2
A

75
50

35
Control

48 hr.

72 hr.

32

University Scholar Thesis
B

Vector

Treatment

Signal (AUC)

Relative Expression

pCTL

Complete media – 24 hrs

11749.326

pPKM2

Complete media – 24 hrs

27873.154

pCTL

DMEM – 48 hrs

7191.447

pPKM2

DMEM – 48 hrs

16320.175

pCTL

DMEM – 72 hrs

7182.548

pPKM2

DMEM – 72 hrs

14673.832

1.00
2.37
0.61
1.39
0.61
1.25

C

D
MW

pCTL

pPKM2 pCTL

pPKM2 pCTL pPKM2

25
20

LC3B-I
LC3B-II

15

Control

48 hr.

72 hr.

33

University Scholar Thesis
E

Vector

Treatment

pCTL

Signal (AUC)
LC3B-II

Signal(AUC)
LC3B-I

Signal Ratio
(II:I)

Complete
media – 24
hrs

11062.711

19230.317

0.58

pPKM2

Complete
media – 24
hrs

13523.054

25926.782

0.52

pCTL

DMEM – 48
hrs

10888.125

12800.468

0.85

pPKM2

DMEM – 48
hrs

18376.054

27788.175

0.66

pCTL

DMEM – 72
hrs

16444.711

19109.832

0.86

pPKM2

DMEM – 72
hrs

29931.681

23435.560

1.28

F

Figure 15. The Resource Depletion-Induced Autophagy Model (Depletion Autophagy Model).
(A) Wild-type (WT), knockdown (KD) and overexpression (OE) cell autophagy levels and cell
viability are plotted as functions of starvation time. WT relative autophagy increases as
starvation time increases, and cell viability decreases concurrently. KD and OE autophagy
levels increase at a greater rate after 60 hours and cell viability decreases at a slower rate.
(B) All curves are shown in this plot. The boxed area indicates the “therapeutic window,” or
the area at which targeting autophagy leads to heightened effects on cell viability. (C) A
schematic showing the DAM in HCC cells.
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Figure 16. MTS assay transformed to cell viability for wild-type, knockdown, overexpression,
and overexpression plus autophagy inhibitor 3-methyladenine (3-MA).
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